Mycophenolic Acid: all 424 studies that test it
Page 4 of 5. Open to participants first (37), then studies with results posted, then the rest; newest registration first within each.
- Therapeutic Effect of Low-dose Prednisone Combined With MMF and FK506 in Focal Segmental GlomerulosclerosisStatus unknownNCT00956059Not applicable
- Intensified Dosing of Cellcept (Mycophenolate Mofetil) in Kidney TransplantationCompletedNCT00943228Phase 4
- Minimizing Immunosuppression in Old for Old Kidney TransplantationCompletedNCT00912678Phase 4
- Bioequivalency Study of Mycophenolate Mofetil 500 mg Tablets Under Fasted ConditionsCompletedNCT00894088Not applicable
- Bioequivalency Study of Mycophenolate Mofetil 500 mg Tablets Under Fed ConditionsCompletedNCT00893958Not applicable
- Bioequivalency Study of Mycophenolate Mofetil 250 mg Capsules Under Fed ConditionsCompletedNCT00893919Not applicable
- Bioequivalency Study of Mycophenolate Mofetil 250 mg Capsules Under Fasted ConditionsCompletedNCT00893542Not applicable
- Efficacy and Safety of Human Lipoprotein Lipase (LPL)[S447X] Expressed by an Adeno-Associated Viral Vector in LPL-deficient SubjectsCompletedNCT00891306Phase 2/3
- Safety Study of Calcineurin-Inhibitor-Free Immunosuppression After Liver TransplantationStatus unknownNCT00890253Phase 2
- Tandem Stem Cell Transplantation for Non-Hodgkin's LymphomaActive, not recruitingNCT00882895Phase 2
- Assess the Efficacy and Safety of Multi-target Therapy in Lupus NephritisCompletedNCT00876616Not applicable
- Mycophenolate Mofetil for IgA NephropathyCompletedNCT00863252Phase 4
- Safety Study of Calcineurin Inhibitor Free GvHD Prophylaxis in Allogeneic Stem Cell TransplantationStatus unknownNCT00856505Phase 1/2
- Mycophenolate Mofetil Maintenance Therapy for Liver TransplantationWithdrawnNCT00849238Not applicable
- A Study of the Impact of an Early Biopsy in Patients Treated With CellCept (Mycophenolate Mofetil) After Kidney TransplantationCompletedNCT00817687Phase 4
- Pharmacokinetics of Immunosuppressive Drugs in Heart Transplant PatientsCompletedNCT00812786Phase 4
- CLEAR Study - A Study of CellCept (Mycophenolate Mofetil) in Recipients of Kidney TransplantsCompletedNCT00788567Phase 3
- CellCept® Dose Adjustment Versus Fixed Dose (Standard Care) in Renal Transplant RecipientsStatus unknownNCT00737659Phase 4
- Phase IV Study to Evaluate Calcineurin Inhibitor Reduced, Steroid Free Immunosuppression After Renal TransplantationCompletedNCT00724022Phase 4
- Sequential Therapy (FK506 + Monoclonal Anti-IL2R Antibodies + MMF) Versus FK506 With Steroids in Liver TXCompletedNCT00693524Phase 2
- Mycophenolate Mofetil (MMF) Discontinuation From a Tacrolimus/MMF/Steroid Triple Regimen After Kidney TransplantationCompletedNCT00693381Phase 3
- Total Marrow Irradiation for Refractory Acute LeukemiaCompletedNCT00686556Phase 1
- A Study to Assess the Effect of CellCept (Mycophenolate Mofetil) and Reduced Corticosteroids in Controlling Symptoms of Myasthenia GravisCompletedNCT00683969Phase 3
- Tacrolimus/Sirolimus Versus Tacrolimus/Mycophenolate Mofetil (MMF) Versus Neoral/Sirolimus in Adult, Primary Kidney TransplantationCompletedNCT00681213Phase 4
- Patient Reported Outcomes in Renal Transplant Patients Tolerating Gastrointestinal (GI) Symptoms Converted to Myfortic (EC-MPS)Status unknownNCT00676221Phase 4
- Mycophenolate Mofetil (MMF) in Patients With IgA Nephropathy (IgAN)CompletedNCT00657059Phase 3
- Trial of Calcineurin Inhibitor-Sparing Immunosuppression Regimen in Pediatric Liver TransplantationTerminatedNCT00656266Phase 4
- A Study to Compare Early Steroid Withdrawal and Long-Term Steroid Maintenance Therapy in Kidney Transplant PatientsCompletedNCT00650468Phase 4
- Conversion From Mycophenolate Mofetil to Mycophenolate Sodium in Renal TransplantCompletedNCT00646737Phase 4
- Combination Therapy Using Cellcept and Rebif in RRMSCompletedNCT00618527Early Phase 1
- Gastrointestinal Tolerability of MMF vs EC-MPS in Maintenance Transplant Patients Treated With Calcineurin InhibitorsStatus unknownNCT00611494Phase 4
- Campath, Rituximab, and Myfortic With Short-Course Calcineurin Inhibitor Therapy in Renal TransplanationTerminatedNCT00579592Not applicable
- Mycophenolate Sodium Treatment in Patients With Primary Sjogren's SyndromeCompletedNCT00542763Phase 1
- Myfortic vs. Cellcept in Kidney Transplant RecipientsCompletedNCT00533624Phase 2/3
- Induction of Mixed Hemopoietic Chimerism in Patients Using Fludarabine, Low Dose TBI, PBSC Infusion and Post Transplant in Immunosuppression w/CSA & Mycophenolate MofetilStatus unknownNCT00531635Phase 1
- Myfortic Versus Azathioprine in Systemic Lupus ErythematosusTerminatedNCT00504244Phase 3
- Cord Blood Expansion on Mesenchymal Stem CellsCompletedNCT00498316Phase 1
- MMF vs. AZA for Kidney TransplantationCompletedNCT00494741Phase 4
- Effects of Immunosuppression on HCV Recurrence After Living Donor Liver Transplantation - Comparative Study Between Tacrolimus + MMF and Tacrolimus + SteroidCompletedNCT00469131Phase 3
- Myfortic in Heart Transplant Patients With Gastrointestinal (GI) SymptomsStatus unknownNCT00468936Phase 3
- Maintenance Neoral Monotherapy Compared to Bitherapy in Renal TransplantationCompletedNCT00461825Phase 3
- A Randomized Multicenter Double-Blind CT to Evaluate the Efficacy and Safety of Mycophenolate Mofetil . . .TerminatedNCT00451867Phase 3
- Genetic Drug Study of Mycophenolic Acid (CellCept) in Pediatric Kidney Transplant PatientsTerminatedNCT00433953Phase 1
- Mycophenolate Mofetil in Systemic SclerosisCompletedNCT00433186Phase 1
- Shift to Everolimus (RAD) Kidney Sparing StudyTerminatedNCT00420537Phase 4
- A Study of CellCept (Mycophenolate Mofetil) in Kidney Transplant Patients Switched From EC-MPS.TerminatedNCT00420472Phase 4
- Clinical Trial of Mycophenolate Versus Cyclophosphamide in ANCA VasculitisCompletedNCT00414128Phase 2/3
- A Continuation Study to Assess the Effect of CellCept in Patients With Myasthenia Gravis.CompletedNCT00408213Phase 3
- CellCept in p-ANCA VasculitisCompletedNCT00405860Phase 1
- Immunosuppressive Therapy With Certican (Everolimus) After Lung TransplantationCompletedNCT00402532Phase 3
- Umbilical Cord Blood T-Regulatory Cell Infusion Followed by Donor Umbilical Cord Blood Transplant in Treating Patients With High-Risk Leukemia or Other Hematologic DiseasesTerminatedNCT00376519Phase 1
- Study to Evaluate Safety and Efficacy of Early Calcineurin Inhibitor Withdrawal in Primary Renal AllograftsCompletedNCT00374647Phase 4
- Comparing the Efficacy of Tacrolimus and Mycophenolate Mofetil for the Initial Therapy of Active Lupus NephritisCompletedNCT00371319Phase 4
- MMF After Pediatric Liver TransplantationCompletedNCT00367146Not applicable
- Exchange of Azathioprine by Mycophenolatmofetile and Cyclosporine A Dose Reduction After Heart TransplantationCompletedNCT00359814Not applicable
- Withdrawal of Steroids, Cyclosporine A Dose Reduction and Switch to Mycophenolatmofetile After Heart TransplantationCompletedNCT00359658Not applicable
- A Pilot Study to Evaluate the Co-Infusion of Ex Vivo Expanded Cord Blood Cells With an Unmanipulated Cord Blood Unit in Patients Undergoing Cord Blood Transplant for Hematologic MalignanciesCompletedNCT00343798Phase 1
- Pharmacogenetic Study of CellCept (Mycophenolate Mofetil) in Kidney Transplant Patients.CompletedNCT00337493Phase 4
- Safety and Efficacy of Cellcept and Avonex as Combination Treatment in Multiple SclerosisCompletedNCT00324506Phase 2
- IMPROVE: Mycophenolate Mofetil Versus Azathioprine for Maintenance Therapy in ANCA Associated Systemic VasculitisTerminatedNCT00307645Phase 3
- Tacrolimus and MMF as Post Grafting Immunosuppression After Conditioning With Flu TBI for HLA Matched Family DonorStatus unknownNCT00304720Phase 2
- MMF Versus CTX in the Induction Treatment of ANCA Associated VasculitisCompletedNCT00301652Not applicable
- Mycophenolate Mofetil (MMF) Versus Intravenous CTX Pulses in the Treatment of Adult Severe HSPNCompletedNCT00301613Not applicable
- Mycophenolate Mofetil Versus Intravenous Cyclophosphamide Pulses in the Treatment of Crescentic IgA NephropathyCompletedNCT00301600Not applicable
- Desensitization of Renal Transplant CandidatesCompletedNCT00298883Phase 1
- Myfortic - Treatment for Extensive cGvHDTerminatedNCT00298324Phase 3
- Chemotherapy and Total-Body Irradiation Followed by Donor Umbilical Cord Blood Transplant, Cyclosporine, and Mycophenolate Mofetil in Treating Patients With Hematologic CancerCompletedNCT00290641Not applicable
- Mycophenolate Mofetil in Myasthenia GravisCompletedNCT00285350Phase 3
- Study Comparing Two Immunosuppressive Regimens in De Novo Renal Allograft RecipientsCompletedNCT00261820Phase 4
- Cyclophosphamide and/or Mycophenolate Mofetil With or Without Tacrolimus in Treating Patients Who Are Undergoing a Donor Bone Marrow or Peripheral Stem Cell Transplant for Hematologic CancerCompletedNCT00255710Phase 1
- Efficacy and Safety of Enteric-coated Mycophenolate Sodium in Heart Transplant RecipientsCompletedNCT00238446Phase 3
- Study of Safety and Efficacy of a Basiliximab, Mycophenolate Mofetil, Cyclosporine Microemulsion and Prednisone Combination Treatment Regimen in Pediatric Renal Allograft RecipientsCompletedNCT00228020Phase 3
- Safety Study of Combination Therapy With Intramuscular Avonex and Oral Cellcept in Patients With Multiple SclerosisCompletedNCT00223301Phase 2/3
- A Kidney Transplant Study to Look at the Effects of Taking Fixed Doses of CellCept Versus Taking Doses of CellCept Based on the Concentration of CellCept in the Blood When Taking Full or Reduced Dose Calcineurin InhibitorsTerminatedNCT00217152Phase 4
- A Pilot Study of Campath-1H Induction Therapy Combined With CellCept® Therapy to Allow for a Calcineurin Inhibitor Free Regimen After Renal TransplantationCompletedNCT00214266Phase 2
- Influence of Sirolimus and MMF on Vascular Function and Markers of Cellular Function in Renal Transplant RecipientsCompletedNCT00204321Phase 4
- MMF and Calcineurin Inhibitor Withdrawal in CANTerminatedNCT00204230Not applicable
- Mycophenolate Mofetil Versus Azathioprine for Maintenance Therapy of Lupus Nephritis.CompletedNCT00204022Phase 3
- Concentration Controlled Versus Fixed Dose of MMF in Kidney Transplant RecipientsStatus unknownNCT00199667Phase 4
- Comparison of Immunosuppression Protocols After LTx in ChildrenCompletedNCT00195988Phase 4
- Pilot Study of Mycophenolate Mofetil in Congenital UropathiesCompletedNCT00193635Phase 1
- Pharmacokinetics of Mmf and ValganciclovirCompletedNCT00189150Phase 4
- MPA PK Monitoring Strategy With MMF/FK Based ImmunosuppressionCompletedNCT00187941Early Phase 1
- Pilot Trial for Implementation of a MPA PK Monitoring StrategyCompletedNCT00187915Not applicable
- Enteric Coated Myfortic for Liver Transplant RecipientsWithdrawnNCT00167492Phase 4
- The Effect of Sirolimus on the Pharmacokinetics of TacrolimusStatus unknownNCT00166829Phase 4
- Fixed Dose MMF vs Concentration Controlled MMF After Renal TransplantationCompletedNCT00166244Phase 4
- Outcomes in Pediatric Heart Transplant Recipients Receiving CellceptTerminatedNCT00166153Not applicable
- Impact of Immunosuppressive Regimens on Polyomavirus-related Transplant NephropathyCompletedNCT00160966Phase 4
- Reduction of Tacrolimus Dose in Association With Mycophenolate Mofetil After Liver TransplantationTerminatedNCT00151632Phase 3
- Follow-up Study of Safety of Enteric-coated Mycophenolate Sodium in Patients Who Successfully Completed Study CERL080A301CompletedNCT00149929Phase 3
- Follow-up Study of Safety of Enteric-coated Mycophenolate Sodium in Patients Who Successfully Completed Study CERL080A0107CompletedNCT00149916Phase 3
- Study of Enteric-coated Mycophenolate Sodium Versus Mycophenolate Mofetil in Adult de Novo Renal Transplant PatientsCompletedNCT00149903Phase 3
- Follow-up Study of Safety of Enteric-coated Mycophenolate Sodium in Patients Who Successfully Completed Study CERL080A302CompletedNCT00149864Phase 3
- Pharmacokinetics of Mycophenolate Mofetil in Healthy VolunteersCompletedNCT00128947Phase 1
- Heart Spare the Nephron (STN) Study - A Study of CellCept (Mycophenolate Mofetil) and Rapamune (Sirolimus) in Heart Transplant RecipientsTerminatedNCT00121784Phase 4
- Fludarabine, Total-Body Irradiation, and Donor Stem Cell Transplant Followed By Cyclosporine and Mycophenolate Mofetil in Treating Patients With Chronic Myelogenous LeukemiaCompletedNCT00119340Phase 1/2
- Mycophenolate Mofetil for Treatment of Relapses of Wegener's Disease or Microscopic Polyangiitis (MPA)CompletedNCT00103792Phase 3
- Freedom Study: Myfortic in Kidney Transplant PatientsCompletedNCT00101738Phase 3
- Efficacy and Safety of FTY720 in Patients Who Receive a Kidney TransplantCompletedNCT00099736Phase 3